Business

China Orders State Firms to Speed AI Rollout Across Manufacturing

China's SASAC directed central state-owned enterprises to accelerate AI adoption across manufacturing, from R&D to production and management.

Xi Jinping Urges China, US Youth to Advance Bilateral Cooperation

President Xi Jinping told students from 10 US universities he hopes young people will advance China-US cooperation in a reply to their letter.

China Tests Star-Based Navigation for Its 2030 Jupiter Mission

Chinese researchers tested stellar aberration navigation aboard the Tianhui-7 satellite in January, fixing its position to within 5km ahead of a 2030 Jupit

Hong Kong Cuts Subsidised Physiotherapy Places by a Third for 2027-28

Hong Kong's Education Bureau cut subsidised physiotherapy places by about a third for 2027-28 as graduates face a tightening job market

China Sets 2030 Target for Public Cultural Services in 15th Five-Year Plan

China's Ministry of Culture and Tourism issued a 15th Five-Year Plan for public cultural services, setting 2030 targets and 18 key engineering projects.

Broadridge Quarterly Profit Climbs on Strength in Investor Communications Segment

Broadridge Financial Solutions posted higher quarterly profit, driven by strength in its investor communications segment amid robust shareholder activity.

US Joins Japan in Rare Yen Intervention to Curb Volatility and Steady Asian Markets

The US bought yen alongside Japan to curb currency volatility and reduce risks to Asian markets, Treasury Secretary Scott Bessent said, in a rare joint mov

Oil Pares Gains as Bessent Signals Hormuz Deal Could Land Within Days

Crude prices eased after US Treasury Secretary Bessent signaled a Strait of Hormuz reopening deal could come within days, emphasizing freedom of movement.

JPMorgan’s Dimon Spearheads Cross-Industry Coalition to Address Emerging AI Risks

JPMorgan CEO Jamie Dimon is spearheading a new cross-industry effort to tackle the risks posed by rapid advances in artificial intelligence.

CVS Beats Estimates and Raises Profit Forecast on Stronger Drug Revenues

CVS Health topped earnings estimates and raised its annual profit forecast on stronger drug revenues, unveiling a new Eli Lilly collaboration for Zepbound

AMD Shares Tumble Despite Earnings Beat as Investors Demand Bigger AI Payoff

AMD shares dropped about 8% in premarket trading despite beating expectations, as investors demanded bigger returns from its AI chip business.

Fiserv Shares Slide as Fintech Cuts Outlook, Warns of Possible Revenue Decline in 2026

Fiserv shares dropped after the fintech company cut its full-year outlook and warned that organic revenue growth could turn negative in 2026.

FDA Approves Moderna’s mFlusiva, the First mRNA Flu Vaccine for Older Adults

The FDA has approved mFlusiva, Moderna's mRNA-based flu shot for adults 50 and older, the first influenza vaccine built on mRNA technology.

DoorDash Stock Surges as Analyst Projects 45% Upside on Growing Order Volume

DoorDash shares jump as analyst Mark Mahaney projects 45% upside, citing growing order volume and an expanding subscriber base for the delivery platform.

Versant Raises 2026 Outlook as Platforms Business and Advertising Drive Earnings Beat

Versant Media raised its full-year 2026 guidance after a Q2 earnings beat driven by growth in its platforms segment and stronger advertising revenue.

Asian Tech Stocks Slide as SK Hynix Suffers Brief Flash Crash Amid AI Sell-Off

SK Hynix briefly plunged 30% in a flash crash as Asian tech stocks fell on a Wall Street AI sell-off, though analysts say the investment cycle holds.

Asia Tech Sell-Off Rattles Markets but Leaves AI Investment Cycle Intact, Analysts Say

Asian tech shares have dropped up to 30%, hurting Chinese fund managers who chased AI plays, but analysts say the AI investment cycle remains on track.

Investors Rotate Toward Healthcare Stocks as Technology Trade Faces Growing Turbulence

Wall Street investors are rotating toward healthcare stocks for stability as the technology trade shows signs of strain and heightened volatility.

Eli Lilly Tops Estimates and Lifts Outlook as GLP-1 Drug Sales Surge

Eli Lilly beat quarterly estimates and lifted its 2026 revenue outlook to $85-$87 billion as Mounjaro and Zepbound sales surged 48%.

- A word from our sponsors -

spot_img

Follow us

HomeBusiness